Rapid Micro Biosystems Inc (RPID)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$0.68-1.53%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · RPID
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -79.1% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 26.9% |
Growth built into the price is above our model estimate.
The price assumes 105.9 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is on a run of consecutive earnings misses and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 29 industry peers
RPID — earnings miss
Dated 2026-08-07
Results of Operations and Financial Condition. On August 7, 2026, Rapid Micro Biosystems, Inc. (the “Company”) issued a press release announcing its financial results for its second quarter ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety. The information furnished under Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18…
Why it matters: Recurring revenue was 63% of Q2 sales, but its growth rate fell from 28% in Q1 to 14% in Q2. Another drop would weaken this growth signal.
Watch forQ3 recurring revenue grows more than 14% year over year.
Also watch forQ3 recurring revenue growth falls below 10% year over year.
Why it matters: Q2 gross margin rose to 15%. A move into the guided mid-20% range would show that margin gains are continuing.
Supportive ifQ3 gross margin is at least 24%, near the stated mid-20% second-half range.
Worry ifQ3 gross margin stays below 20%, or management lowers its full-year margin goal of about 20%.
Why it matters: Q2 revenue was $8.1M, and management kept its full-year range. Q3 revenue will show whether sales are gaining pace.
Watch forQ3 revenue is at least $9.8M, keeping the company on pace for the $37M low end.
Also watch forQ3 revenue is below $9.8M, and management cuts its $37M–$41M full-year revenue range.
Why it matters: The placement range is part of the full-year plan. Q1 and Q2 had 10 placements together, so the second half needs 20 to 28.
Watch forThe company reports at least 30 total system placements for 2026.
Also watch forThe company reports fewer than 30 placements, or lowers its 30-to-38 placement range.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$172 on $10,000 · ±1.7% | How much price usually moves either way. |
| Bad day | $712 loss on $10,000 · 7.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,544 loss on $10,000 · 85.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.